Thermo Fisher Scientific (TMO) Minority Interest (2009 - 2026)

Thermo Fisher Scientific has disclosed Minority Interest across 8 years of filings, most recently posting $7.0 million for Q1 2026.

• Quarterly Minority Interest fell 94.53% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (down 94.53% YoY) and the FY2025 annual result came in at $7.0 million, down 94.17% from the prior year.
• Minority Interest held at $7.0 million in Q1 2026, from $7.0 million in the prior quarter.
• Over five years, Minority Interest peaked at $129.0 million in Q3 2025 and troughed at $7.0 million in Q4 2025.
• A 5-year average of $106.8 million and a median of $118.0 million in 2023 frame the typical range for Minority Interest.
• Annual changes were most pronounced in 2025 — Minority Interest advanced 9.57% — and 2026, when it tumbled 94.53%.
• Tracing TMO's Minority Interest over 5 years: stood at $116.0 million in 2022, then rose by 1.72% to $118.0 million in 2023, then grew by 1.69% to $120.0 million in 2024, then slumped by 94.17% to $7.0 million in 2025, then changed by 0.0% to $7.0 million in 2026.
• Business Quant data shows TMO's Minority Interest at $7.0 million in Q1 2026, $7.0 million in Q4 2025, and $129.0 million in Q3 2025.